INTRODUCTION
Dengue is a systemic viral infection transmitted between humans by mosquitoes. It is a self-limiting illness. With more than one-third of the world's population living in areas at risk for infection, dengue virus is a leading cause of illness and death in the tropics and subtropics. The global burden of dengue is large; an estimated 50 million infections per year occur across approximately 100 countries, with potential for further spread. 1 Dengue Fever (DF) is characterized by fever, headache, muscle or joint pain, and rash. In some cases, however, patients develop the life-threatening complication, Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). Present evidence suggests that haemorrhage in DHF/DSS is related to multiple factors that include thrombocytopenia, coagulopathy, and vasculopathy. In our study we tried to find out the prevalence of coagulopathy in DF patients having thrombocytopenia and its clinical significance.
METHODS
The study was done in a tertiary care centre in South India. Patients admitted to medical wards and ICU were included in the study. Those patients who were included in the study group were monitored for bleeding manifestations. Activated Partial Thromboplastin Time (APTT) and Prothrombin Time (PT) were done in the study population as part of routine investigations.
Those with prolonged APTT values were again subjected to mixing studies with normal plasma for normalisation of APTT. D-dimer assay was done in those patients with persistently abnormal APTT values even after mixing studies.
Coagulopathy is considered when APTT values were ≥41 seconds. APTT values ≤40 were considered as normal. Mixing studies were done only in patients with presence of coagulopathy.
RESULTS
Out of the 264 patients included in the study, 72 (27.3%) patients had bleeding manifestations. Bleeding manifestations were absent in 192 (72.7%) patients. Presence of coagulopathy (APTT ≥41 sec) was present in 59 (22.3%) patients. 205 (77.7%) did not show any evidence of coagulopathy. Prothrombin time was normal in all the patients. In our study APTT of each patient was checked, and was arranged into a categorical data of 6 groups, with group 1 being the lowest APTT count and group 6 being the highest APTT count (Table 1) . When cross tabulated with bleeding manifestation, it was found by Pearson Chisquare, that P value was <0.001. This suggests that bleeding manifestation significantly increased with increasing APTT values.
The APTT values were then categorised as normal (≤40 seconds) and abnormal (≥41 seconds) and then compared for the presence of bleeding ( Table 2 ). The result was highly significant with a P value of <0.001. This also suggests that abnormal APTT values are associated with significantly increased risk of bleeding manifestations (Table  3) . Chi-Square analysis of this data showed no statistical correlation in the prevalence of bleeding manifestation in these two groups (P >0.05). All the seven patients with persistently elevated APTT values even after mixing studies had elevated D-dimer values. The study population was then divided into six groups based on the platelet counts (Table 4) . Bleeding manifestations were assessed in these six groups of patients. It was found that the P value is <0.001, indicating that there is significant association between platelet counts and bleeding manifestations.
The six groups of APTT values and platelet counts were compared. It was found that the Spearman rank correlation coefficient of -0.343 is present between these two variables, with a P value of <0.001. This suggests that the finding is statistically significant. That means, as the platelet count drops, APTT value raises. 
DISCUSSION
Bleeding manifestations are an important clinical feature in DF. Mostly it is due to the low platelet count seen in these patients. But a significant proportion of bleeding manifestations are due to the presence of coagulopathy associated with DF. Some studies showed a high prevalence of coagulopathy of 50%, 2 but our study showed only a prevalence of only 22.3%. Coagulopathy as indicated by APTT prolongation shows abnormality in the intrinsic pathway of coagulation which lasts only for few days during the disease course. No abnormality of extrinsic pathway was found as indicated by normal PT in our study and in other earlier studies. 2 Certain studies had shown the role of IL-6 in down regulating the synthesis of factor XII, the first factor to initiate the intrinsic pathway of coagulation. APTT prolongation in the DF patients is caused by a lack of intrinsic pathway probably due to impaired synthesis of coagulation factor. 3 There are also studies showing role of activation of fibrinolytic system responsible for bleeding manifestations in dengue fever in addition to the thrombocytopenia and APTT prolongation. 3 But this was not assessed in our study because of lack of infrastructure facilities and also the high cost of investigations. This mechanism maybe responsible for the persistent elevation of APTT values in some patients even after doing mixing studies with normal plasma as evidenced by elevated Ddimer results in our study.
CONCLUSION
Dengue fever is associated with transient coagulopathy during the course of the illness. According to our study the prevalence of coagulopathy in Dengue fever is 22.3%.
In addition to the thrombocytopenia, the coagulopathy is also contributing to the bleeding manifestations seen in Dengue fever patients. Our study showed a significant correlation between bleeding manifestations with abnormal APTT values. Also the risk significantly increased with increasing values of APTT. Our study also showed a significant correlation between thrombocytopenia and abnormal APTT values which was not demonstrated in previous studies. We found that as platelet count decreases there is tendency for rise in APTT values.
